Q1 2017 Holdings
Filed 2017-05-09 | 11 holdings | $153.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals | Common Stock | 699374302 | $50.1K | 2,600,410 | 32.5% |
| Juno Therapeutics | Common Stock | 48205A109 | $27.3K | 1,229,512 | 17.7% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $20.0K | 812,492 | 13.0% |
| Egalet | Common Stock | 28226B104 | $14.7K | 2,889,926 | 9.6% |
| Nabriva Therapeutics | Sponsored ADR | 62957M104 | $13.8K | 1,145,890 | 8.9% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $12.7K | 579,650 | 8.3% |
| Essa Pharma | Common Stock | 29668H104 | $5.3K | 1,696,969 | 3.4% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $4.4K | 1,697,384 | 2.9% |
| Cidara Therapeutics | Common Stock | 171757107 | $3.5K | 444,965 | 2.3% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $1.3K | 301,477 | 0.8% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $760 | 223,457 | 0.5% |